- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer Suppression by the Chromosome Custodians, BRCA1 and BRCA2
Authors
Keywords
-
Journal
SCIENCE
Volume 343, Issue 6178, Pages 1470-1475
Publisher
American Association for the Advancement of Science (AAAS)
Online
2014-03-28
DOI
10.1126/science.1252230
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies
- (2013) J.-m. Lee et al. ANNALS OF ONCOLOGY
- Wip1 Controls Global Heterochromatin Silencing via ATM/BRCA1-Dependent DNA Methylation
- (2013) Doria Filipponi et al. CANCER CELL
- Function of BRCA1 in the DNA Damage Response Is Mediated by ADP-Ribosylation
- (2013) Mo Li et al. CANCER CELL
- Cumulative Haploinsufficiency and Triplosensitivity Drive Aneuploidy Patterns and Shape the Cancer Genome
- (2013) Teresa Davoli et al. CELL
- High Prevalence of BRCA1 and BRCA2 Germline Mutations with Loss of Heterozygosity in a Series of Resected Pancreatic Adenocarcinoma and Other Neoplastic Lesions
- (2013) A. L. Lucas et al. CLINICAL CANCER RESEARCH
- The interaction between CtIP and BRCA1 is not essential for resection-mediated DNA repair or tumor suppression
- (2013) Colleen R. Reczek et al. JOURNAL OF CELL BIOLOGY
- Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
- (2013) Nasim Mavaddat et al. JNCI-Journal of the National Cancer Institute
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- A cancer-associated BRCA2 mutation reveals masked nuclear export signals controlling localization
- (2013) Anand D Jeyasekharan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- 53BP1 Regulates DSB Repair Using Rif1 to Control 5' End Resection
- (2013) M. Zimmermann et al. SCIENCE
- High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus inBRCA2mutation carriers with aggressive prostate cancer
- (2012) Amber Willems-Jones et al. BJU INTERNATIONAL
- A DNA-Damage Selective Role for BRCA1 E3 Ligase in Claspin Ubiquitylation, CHK1 Activation, and DNA Repair
- (2012) Ko Sato et al. CURRENT BIOLOGY
- BRCA2 Fine-Tunes the Spindle Assembly Checkpoint through Reinforcement of BubR1 Acetylation
- (2012) Eunhee Choi et al. DEVELOPMENTAL CELL
- BRCA2 Localization to the Midbody by Filamin A Regulates CEP55 Signaling and Completion of Cytokinesis
- (2012) Gourish Mondal et al. DEVELOPMENTAL CELL
- STRING v9.1: protein-protein interaction networks, with increased coverage and integration
- (2012) Andrea Franceschini et al. NUCLEIC ACIDS RESEARCH
- BRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance
- (2011) Rinske Drost et al. CANCER CELL
- Double-Strand Break Repair-Independent Role for BRCA2 in Blocking Stalled Replication Fork Degradation by MRE11
- (2011) Katharina Schlacher et al. CELL
- Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell Fate
- (2011) Theresa A. Proia et al. Cell Stem Cell
- A genetic screen identifies BRCA2 and PALB2 as key regulators of G2 checkpoint maintenance
- (2011) Tobias Menzel et al. EMBO REPORTS
- Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas
- (2011) Barbara Norquist et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients WithBRCA1orBRCA2Mutations and Recurrent Ovarian Cancer
- (2011) Stan B. Kaye et al. JOURNAL OF CLINICAL ONCOLOGY
- Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
- (2011) Karen A Gelmon et al. LANCET ONCOLOGY
- BRCA1 tumour suppression occurs via heterochromatin-mediated silencing
- (2011) Quan Zhu et al. NATURE
- A mitotic function for the high-mobility group protein HMG20b regulated by its interaction with the BRC repeats of the BRCA2 tumor suppressor
- (2011) M Lee et al. ONCOGENE
- BRCA1 Tumor Suppression Depends on BRCT Phosphoprotein Binding, But Not Its E3 Ligase Activity
- (2011) R. Shakya et al. SCIENCE
- Germline Brca2 Heterozygosity Promotes KrasG12D -Driven Carcinogenesis in a Murine Model of Familial Pancreatic Cancer
- (2010) Ferdinandos Skoulidis et al. CANCER CELL
- 53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
- (2010) Samuel F. Bunting et al. CELL
- BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells
- (2010) Gemma Molyneux et al. Cell Stem Cell
- Cytokinesis failure occurs in Fanconi anemia pathway–deficient murine and human bone marrow hematopoietic cells
- (2010) Patrizia Vinciguerra et al. JOURNAL OF CLINICAL INVESTIGATION
- Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses inBRCACarrier Ovarian Cancer Correlating With Platinum-Free Interval
- (2010) Peter C. Fong et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
- Purified human BRCA2 stimulates RAD51-mediated recombination
- (2010) Ryan B. Jensen et al. NATURE
- The CHK2–BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells
- (2010) Ailine Stolz et al. NATURE CELL BIOLOGY
- Human BRCA2 protein promotes RAD51 filament formation on RPA-covered single-stranded DNA
- (2010) Jie Liu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The breast cancer tumor suppressor BRCA2 promotes the specific targeting of RAD51 to single-stranded DNA
- (2010) Tina Thorslund et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
- (2010) Peter Bouwman et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- brca2 in zebrafish ovarian development, spermatogenesis, and tumorigenesis
- (2010) H. R. Shive et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The BRC Repeats of BRCA2 Modulate the DNA-Binding Selectivity of RAD51
- (2009) Aura Carreira et al. CELL
- The Carboxyl Terminus of Brca2 Links the Disassembly of Rad51 Complexes to Mitotic Entry
- (2009) Nabieh Ayoub et al. CURRENT BIOLOGY
- PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response
- (2009) Feng Zhang et al. CURRENT BIOLOGY
- Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy
- (2009) Tomasz Byrski et al. JOURNAL OF CLINICAL ONCOLOGY
- Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
- (2009) Elgene Lim et al. NATURE MEDICINE
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two modules in the BRC repeats of BRCA2 mediate structural and functional interactions with the RAD51 recombinase
- (2009) Eeson Rajendra et al. NUCLEIC ACIDS RESEARCH
- The BRC repeats of human BRCA2 differentially regulate RAD51 binding on single- versus double-stranded DNA to stimulate strand exchange
- (2009) M. K. K. Shivji et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PALB2 is an integral component of the BRCA complex required for homologous recombination repair
- (2009) S. M. H. Sy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Linking the Cellular Functions of BRCA Genes to Cancer Pathogenesis and Treatment
- (2008) Ashok R. Venkitaraman Annual Review of Pathology-Mechanisms of Disease
- Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
- (2008) Wataru Sakai et al. NATURE
- Resistance to therapy caused by intragenic deletion in BRCA2
- (2008) Stacey L. Edwards et al. NATURE
- E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks
- (2008) L. J. Reid et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BRCA1 regulates human mammary stem/progenitor cell fate
- (2008) S. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started